DFX Intelligence

Data Factory

Private creditBorrowerpharmaceuticalsaunknown

Centrexion Therapeutics, Inc

sponsor (inference, pe portfolio stem): Catalio Capital Management, LP

Search this name across graphsid dfx:pc:fee74f82-b84c-7339-137c-c4cbeb7582f7

Data as of Jun 30, 2026 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 19, 2026, 4:58 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 5
On other graphs: 1
Observed: Dec 31, 2022 to Jun 30, 2026
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Centrexion Therapeutics Corp

name equal in sponsor portfolio · confidence 95% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 2
BDCs: 1
Facilities: 2
Fair value, latest: $0
First on a schedule: Dec 31, 2022
Last on a schedule: Jun 30, 2026
Sponsor basis: pe_portfolio_steminferencedeal party is a fact; a portfolio stem or a Form D signer is an inference

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
warrant	equity	n/a	$0	n/a	n/a	n/a	n/a	1	2	Unknown	Jun 30, 2026
Term loan	First lien	$26.0M	$27.6M	Jan 1, 2024	Xbrl fact	0	n/a	2	2	Unknown	Dec 31, 2022

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
SLR Investment Corp.	1	$0	$0	$0	n/a	Jun 30, 2026

Relationships

Sponsors (1)

← Catalio Capital Management, LPSponsor of borrowersPE portfolio stem
Sep 15, 2026 to presentinferenceDFX's own graph

Dated events

3 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Dec 31, 2022
Borrower first appears on a BDC schedule
Centrexion Therapeutics, Inc first appears in a BDC schedule (2 lenders)
SLR Investment Corp.BDC schedule of investmentsobserved 2.9 years ago
$26.0M
Occurred
Dec 31, 2022
Borrower left every BDC schedule
Centrexion Therapeutics, Inc term loan (first lien) left every BDC schedule after 2022-12-31 (2 lenders, $26.0M last held)
BDC schedule of investments
$26.0M

Show 3 bookkeeping events

Occurred
Dec 31, 2023
SCP Private Credit Income BDC LLC: position exited in Centrexion Therapeutics, Inc
Occurred
Sep 30, 2023
SLR Investment Corp.: position exited in Centrexion Therapeutics, Inc ($23.7M principal)
Occurred
Sep 30, 2023
SCP Private Credit Income BDC LLC: position exited in Centrexion Therapeutics, Inc ($2.3M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:fee74f82-b84c-7339-137c-c4cbeb7582f7
First observed: Dec 31, 2022
Last observed: Jun 30, 2026 2 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Centrexion Therapeutics, Inc

sponsor (inference, pe portfolio stem): Catalio Capital Management, LP

Search this name across graphsid dfx:pc:fee74f82-b84c-7339-137c-c4cbeb7582f7

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

warrant

equity

n/a

Unknown

Jun 30, 2026

Term loan

First lien

$26.0M

$27.6M

Jan 1, 2024

Xbrl fact

n/a

Unknown

Dec 31, 2022

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

SLR Investment Corp.

n/a

Jun 30, 2026